Interesting review of the therapeutic potential of psilocybin and other psychedelics, including recent randomized placebo-controlled trials demonstrating decreases in depression and anxiety, and potential long-lasting reductions in neuroinflammation.

One important thing to keep in mind is that in most clinical trials a history of any mental illness or even that of first degree relatives is exclusion criteria. Lots of research still to be done to determine clinical safety and relevance.

Learn more in this interview with Dr. Griffiths. foundmyfitness.com/episodes/roland-griffiths